BACKGROUND: North American (NA) ginseng (Panax quinquefolius) is a popular natural health product (NHP) that has been demonstrated to regulate immune function, inflammatory processes and response to stress and fatigue. Recent evidence suggests that various extracts of NA ginseng may have different bioactivities because of distinct profiles of ginsenosides and polysaccharides. To date, the bioactive role of ginseng on adipocytes remains relatively unexplored. OBJECTIVE: The goal of this work was to study the extract-specific bioactivity of NA ginseng on differentiated preadipocyte gene expression and adipocytokine secretion. METHODS: In vitro differentiated 3T3-L1 preadipocytes were treated with 25 and 50 mg ml À 1 of either crude ethanol (EtOH) or aqueous (AQ) NA ginseng extracts, or polysaccharide and ginsenoside extracts isolated from the AQ extract. Global gene expression was studied with microarrays and the resulting data were analyzed with functional pathway analysis. Adipocytokine secretion was also measured in media. RESULTS: Pathway analysis indicated that the AQ extract, and in particular the polysaccharide extract, triggered a global inflammomodulatory response in differentiated preadipocytes. Specifically, the expression of Il-6 (interleukin 6), Ccl5 (chemokine (C-C motif) ligand 5), Nfkb (nuclear factor-kappaB) and Tnfa (tumor necrosis factor alpha) was increased. These effects were also reflected at the protein level through the increased secretion of IL-6 and CCL5. No effect was seen with the EtOH extract or ginsenoside extract. Using a specific toll-like receptor 4 (TLR4) inhibitor reduced the upregulation of inflammatory gene expression, indicating the relevance of this pathway for the signaling capacity of NA ginseng polysaccharides. CONCLUSION: This work emphasizes the distinct bioactivities of different ginseng extracts on differentiated preadipocyte signaling pathways, and highlights the importance of TLR4 for mediating the inflammomodulatory role of ginseng polysaccharides.
INTRODUCTION
The medicinal properties of plants have been exploited for centuries for the prevention and treatment of disease; however, the genetic and molecular basis for their use remains poorly understood. A prime example is ginseng, which is widely consumed to boost the immune system, as well as provide resistance to stress and fatigue. 1 Ginseng constitutes a family of herbs in which the primary species are Panax ginseng and Panax quinquefolius. P. ginseng (more commonly known as Asian ginseng) is widely considered to be an adaptogen, mental stimulant and general wellness tonic. 2, 3 In contrast, considerably less is known about the bioactivity of P. quinquefolius (more commonly known as North American (NA) ginseng). Although similar in genus, these species have distinct profiles of bioactive compounds, such as ginsenosides and polysaccharides. 4 Polysaccharides and ginsenosides differ in their physicochemical structures, which therefore affects their solubility in extraction solvents. 3, 4 These compounds are also thought to differ in their ability to modulate cellular signaling pathways. 4, 5 For example, ginsenosides are characterized as steroidal saponins and share structural similarities with steroid hormones. As such, ginsenosides are thought to interact with ion channels, as well as membrane and nuclear receptors. Further evidence suggests that ginsenosides may also alter membrane fluidity. 4 In contrast, plant polysaccharides are thought to exert their activity primarily by binding plasma membrane receptors that activate intracellular signaling cascades, leading to altered gene expression. 5 Initial research has demonstrated that NA ginseng extracts can regulate immune function, inflammatory processes and glucose homeostasis. 3, 6 For example, treating macrophage with aqueous (AQ) ginseng extracts led to a significant increase in the production of several cytokines, such as interleukin 6 (IL-6), tumor necrosis factor alpha (TNFa) and nitric oxide. 3 IL-6 and TNFa have been described as pro-inflammatory cytokines that are involved in a number of functions, including cell cycle regulation, differentiation and metabolic pathways such as insulin signaling. 7, 8 It appears that this inflammodulation may be beneficial when ginseng is provided as an acute treatment, as demonstrated with upper respiratory infections; however, the consequences of long-term treatment have not been fully investigated. 9 The use of NHPs by individuals attempting to lose excess body weight has become more prominent in recent years. 10 Obesity is recognized as a chronic state of low-grade inflammation that is characterized by the expansion of adipose tissue. 7 Adipocytes, the lipid storing cells of adipose tissue, are now recognized to secrete numerous proteins (that is, adipokines) that contribute to the regulation of whole body homeostasis. 7, 11 Because of their role as an active endocrine cell, there is considerable interest to understand how the consumption of foods and NHPs can influence adipocyte function. 12 Preliminary investigations in differentiated 3T3-L1 preadipocytes revealed the potential of various NA ginseng extracts to regulate adipogenesis and increase adiponectin secretion. 13, 14 This suggests that NA ginseng may have potential use for the treatment of obesity-related perturbations, such as the low-grade inflammation; however, this remains poorly investigated.
The goal of the current study was to provide knowledge regarding extract-specific bioactivity of NA ginseng on differentiated preadipocyte global gene expression and adipocytokine secretion. This research provides novel insight regarding the differentiated preadipocyte signaling pathways targeted by distinct ginseng extracts that will be highly relevant for their potential use as a treatment in individuals with a perturbed metabolic status.
MATERIALS AND METHODS

Ginseng acquisition and extraction
Four-year-old ginseng was provided by the Ontario Ginseng Growers Association. Ginseng roots were collected and pooled from five different farms in Ontario, Canada. Samples were then shipped to Naturex (South Hackensack, NJ, USA) and prepared as previously described. 3 All samples tested negative for lipopolysaccharide (LPS) contamination. Crude AQ and ethanol (EtOH) NA ginseng extracts, along with AQ sub-fractions of polysaccharide and ginsenoside extracts, were kindly provided by the Ontario Ginseng Research and Innovation Consortium.
High performance liquid chromatography analysis of the AQ and EtOH extracts showed significant differences in the total ginsenoside (Rb1, Re, Rc, Rd, Rg1 and Rb2) content and profiles. 3, 15 The EtOH extract contained more than twice the total ginsenoside content than the AQ extract: 28.25% versus 13.87% dry weight of extract. Rb1 and Re were the two most predominant ginsenosides in both extracts, but the Rb1/Re ratio was higher in the EtOH extract: 1.8 versus 1. crude ginseng dry weight, mean±s.e.m.) for Re, Rb1, Rc, Rd, Rg1 and Rb2, respectively. 15 In addition, the total polysaccharide content of the various extracts has been previously described. 3 Cell culture materials Mouse 3T3-L1 preadipocytes were obtained from ATCC (Rockville, MD, USA). Cell culture reagents including Dulbecco's modified Eagle's medium and penicillin-streptomycin were purchased from Hyclone laboratories (Logan, UT, USA). Dexamethasone, 3-isobutyl-1-methylxanthine, human insulin, fetal bovine serum and Hanks buffered salt solution were obtained from Sigma Aldrich (Oakville, Ontario, Canada). The toll-like receptor 4 (TLR4) inhibitor CLI-095 and EK ultra pure LPS were purchased from Cedarlane (Burlington, Ontario, Canada).
Cell culture
Mouse 3T3-L1 preadipocytes were seeded at a density of 6.0 Â 10 4 cells per well in six-well plates. Briefly, cells were cultured in Dulbecco's modified Eagle's medium supplemented with 5% fetal bovine serum and 1% penicillin-streptomycin at 37 1C in 5% CO 2 . Differentiation was induced at 2 days post confluence (that is, day 0) using a standard differentiation cocktail consisting of dexamethasone (C f ¼ 1 mM), 3-isobutyl-1-methylxanthine (C f ¼ 0.5 mM) and insulin (C f ¼ 5 mg ml À 1 ). On Day 2, the standard differentiation cocktail was replaced with maintenance media containing only 5 mg ml À 1 insulin. Maintenance media was changed every 2 days for the remainder of the experiment. On Day 7 fetal bovine serum was removed from the media and the duration of the experiment was conducted in serum-free conditions. On Day 8, differentiated preadipocytes were treated for 48 h with either 25 or 50 mg ml À 1 of both the AQ and EtOH ginseng extracts. All extracts were dissolved in Hanks buffered salt solution and filtered with 0.2 mM filters before use. The polysaccharide and ginsenoside sub-fractions (isolated from the crude AQ extract) were also analyzed at 50 mg ml À 1 for 48 h. On Day 10 cell culture media was collected and total RNA extracted from differentiated preadipocytes.
In a separate experiment, differentiated preadipocytes at day 8 were treated for 24 h with 50 mg ml À 1 concentrations of either the AQ or EtOH extracts, or the polysaccharide and ginsenoside sub-fractions, with 0.5 mg ml À 1 of the TLR4 inhibitor in serum-free conditions. Cell culture media was collected and total RNA extracted.
RNA preparation
Total RNA was extracted using the Qiagen RNeasy Mini Kit according to the manufacturer's protocol (Qiagen, Mississauga, Ontario, Canada). RNA was quantified with a Nanodrop 8000 (ThermoScientific, Wilmington, DE, USA) and RNA quality was subsequently verified using the Agilent 2100 bioanalyzer (Agilent Technologies Inc., Santa clara, California, USA). Only samples with an RNA integrity number 49 were used for microarray analysis.
Affymetrix microarray analysis
Total RNA (100 ng) was prepared for hybridization to Affymetrix Mouse Gene 1.1 ST array strips according to manufacturer's instructions (Affymetrix Inc., Fremont, CA, USA). Briefly, total RNA was used to synthesize cDNA and subsequently cRNA. Second cycle cDNA was produced, fragmented, biotin labeled and hybridized to microarrays. Strips were then washed, stained and scanned on the GeneAtlas platform.
Microarray data were quantile normalized and differentially expressed genes were identified using an analysis of variance analysis adjusted for multiple testing with a 1% false discovery rate (JMP Genomics Version 5, SAS, Cary, NC, USA). A P-valueo0.01 was used to identify differentially expressed genes.
FunNet, a functional genomics tool, was used to explore significant coexpression networks. 16 Up and downregulated genes were analyzed separately for each condition using a false discovery rate of 5%. FunNet's internal algorithm and Kyoto Encyclopedia of Genes and Genomes annotations were used to offer insight into the biological pathways regulated by the AQ and EtOH extracts. Gene set enrichment analysis (GSEA) also provided insight into the regulation of previously defined gene sets or co-expression networks. 17 Briefly, data were referenced to the Gene Ontology GSEA database, c5, and permuted on the basis of gene sets; GSEA generates random gene sets on the basis of size and calculates enrichment scores. Only gene sets with a false discovery rate q-value, an estimated probability of a false-positive finding, of o0.25 were considered.
Quantitative real-time PCR Single strand cDNA was synthesized for use in RT-qPCR from 1 mg RNA using a high Capacity cDNA kit (Applied Biosystems, Concord, Ontario, Canada). RT-qPCR was carried out to validate the expression of the following genes: Il-6, Chemokine (C-C motif) Ligand 5 (Ccl5), nuclear factorkappab (Nfkb), Tnfa, (fatty acid-binding protein 4) Fabp4 and peroxisome proliferator-activated receptor gamma (Ppar-g). All RT-qPCR materials were purchased from Bio-Rad (Mississauga, Ontario, Canada). SsoFast EvaGreen master mix was prepared with 0.25 mg cDNA and specific primers. Amplification was conducted on a Bio-Rad CFX-96 using the following protocol: enzyme activation 95 1C for 30 s, initial denaturation at 95 1C for 4 s and annealing/extension at 55.9 1C for 4 s, repeated for 40 cycles. A melt curve was also performed as per the manufacturer's settings. RT-qPCR data were investigated for differences in gene expression; data are expressed as the mean ± s.e.m., where each treatment was performed in quadruplicate. All samples were normalized to the housekeeping gene Rplp0 and assessed using a two tailed, homoscedastic Student's t-test. A P-valueo0.05 was considered significant.
Bioplex investigation of adipocytokine secretion
A BioPlex mouse cytokine 3-plex was custom designed and used with the Bio-Plex 200 system (Bio-Rad). The assay is based on microbead Luminex xMAP technology and a flow based protein detection system. Cell culture media was collected after the 48 h treatment period (with various ginseng extracts) and analyzed for secreted levels of IL-6, CCL5 and TNFa. The cytokine assay plate was prepared according to manufacturer's instructions. Each sample was measured in duplicate to ensure technical reproducibility. The analysis was completed using the Bioplex Manager 6.0 software (Bio-Rad). A P-valueo0.05 was considered significant.
RESULTS
Impact of ginseng extracts on differentiated preadipocyte gene expression Global gene expression profiling was used to investigate the effects of AQ and EtOH ginseng extracts on differentiated preadipocytes. As summarized in Table 1 , treating differentiated preadipocytes with 50 mg ml À 1 of the AQ extract resulted in the upregulation of 490 genes and downregulation of 133 genes. Although treating differentiated preadipocytes with a lower concentration of the AQ extract (25 mg ml À 1 ) led to a smaller number of differentially expressed genes (that is, 400 upregulated and 89 downregulated genes), there was high concordance between the gene lists. Specifically, between the 25 and 50 mg ml À 1 AQ treatments there was 81% overlap in upregulated genes and 66% overlap in downregulated genes. In contrast, treating differentiated preadipocytes with the EtOH ginseng extract had only a minimal effect on adipocyte gene expression. The 50 mg ml À 1 EtOH treatment resulted in 10 upregulated genes and 10 downregulated genes, while the 25 mg ml À 1 EtOH treatment resulted in 9 significant upregulated genes and 13 downregulated genes. Overall, these results suggested that the AQ extract of NA ginseng contained the bioactive molecules capable of regulating differentiated preadipocyte function.
Global functional analyses were performed using the aforementioned gene lists in order to better understand the biological pathways differentially regulated by the various ginseng extracts (Figure 1 ). Functional analyses revealed that numerous inflammatory pathways related to cytokine, chemokine and TLR signaling were upregulated by the 50 mg ml À 1 AQ extract. Those genes downregulated by the AQ treatment were associated with pathways related to extracellular matrix interactions. The biological pathways affected by 25 mg ml À 1 AQ ginseng extract were similar to those identified with the 50 mg ml À 1 AQ ginseng extract (data not shown). Importantly, functional analysis indicated that adipocyte differentiation pathways were not significantly affected by the AQ extract. In light of the low number of genes differentially expressed by the EtOH extracts, the functional analysis software was unable to identify an enrichment of any biological pathways.
As outlined in Supplementary Table 1A and B, GSEA analysis confirmed that various inflammatory and signaling pathways were triggered in differentiated preadipocytes treated with either the 25 or 50 mg ml À 1 AQ ginseng extract. These pathways were consistent with the Kyoto Encyclopedia of Genes and Genomes pathway analysis performed using FunNet software (www.funnet. info). Genes such as Il-6, Ccl5, Nfkb and Tnfa were common to both FunNet and GSEA analyses, and were also amongst the most highly upregulated genes according to their significance ranking (Supplementary Table 2A and B for the lists of the top 50 most highly upregulated and downregulated genes, respectively).
RT-qPCR of candidate inflammation-related genes We next confirmed microarray results by examining a small subset of common inflammation-related genes by RT-qPCR. Expression analysis confirmed that Il-6, Ccl5, Nfkb and Tnfa were upregulated in a dose-dependent manner by the AQ extract (data not shown). Il-6 was very highly upregulated by the AQ treatments, where the 25 and 50 mg ml À 1 AQ extracts led to an B11-and 100-fold increase in gene expression, respectively (Po0.001) (Figure 2a) . Similarly, Ccl5 was significantly upregulated by the 25 and 50 mg ml À 1 AQ extracts by B7.4-and 34-fold, respectively (Po0.001) (Figure 2b) . Nfkb was also upregulated by the 25 and 50 mg ml À 1 AQ extracts by B1.6-and 3.1-fold, respectively (Po0.02) (Figure 2c ), while Tnfa was only significantly upregulated by 3.4-fold with the 50 mg ml À 1 AQ treatment (Po0.05) (Figure 2d ). The expression of these genes was not changed in differentiated preadipocytes treated with the EtOH ginseng extracts. Additionally, we confirmed that neither ginseng extract affected the expression of Ppar-g and Fabp4 (data not shown), which are recognized markers of preadipocyte differentiation.
RT-qPCR investigation of polysaccharide and ginsenoside subfractions To obtain further clarity regarding the bioactive constituents of the AQ ginseng extract, we further sub-fractionated this extract to obtain ginsenoside and polysaccharide-enriched fractions and subsequently re-examined the expression of Il-6, Ccl5, Nfkb and Tnfa by RT-qPCR. When differentiated preadipocytes were treated with 50 mg ml À 1 of the polysaccharide-enriched extract, Il-6 expression increased 13.7-fold (Po0.001), Ccl5 expression increased 3.1-fold (P ¼ 0.002) and Tnfa expression increased 1.5-fold (P ¼ 0.02) (Figures 3a-c) . The 50 mg ml À 1 polysaccharideenriched extract suggested a trend towards an increase in Nfkb expression; however, the results did not achieve statistical significance (P ¼ 0.07; data not shown). Treating differentiated preadipocytes with the 50 mg ml À 1 ginsenoside-enriched fraction led to a minor, yet significant, increase in only Il-6 expression Abbreviations: AQ, aqueous; EtOH, ethanol. Figure 1 . Visualization of differentiated preadipocyte pathways regulated by 50 mg ml À 1 AQ NA ginseng. Microarray data obtained from differentiated preadipocytes treated with the 50 mg ml À 1 AQ ginseng extract was analyzed using FunNet. In all, 490 target genes were upregulated and 133 downregulated in comparison with control cells. A 5% false discovery rate was used to identify overrepresented Kyoto Encyclopedia of Genes and Genomes (KEGG) pathways. Transcriptional domain coverage indicates the most significant biological functions represented amongst annotated genes, ranked by percentage.
(1.7-fold; P ¼ 0.01); however, this sub-fraction did not significantly affect Ccl5, Tnfa or Nfkb gene expression.
Investigation of ginseng signaling via the TLR4 pathway
The functional pathway analysis of our microarray data (Figure 1 ) indicated that ginseng extracts may be affecting adipocyte inflammatory markers via the toll-like receptor pathway. As TLR4 gene expression was unchanged by the various ginseng extracts (data not shown), this suggested that the extracts may be modifying TLR4 downstream signaling. In order to investigate this hypothesis, we treated differentiated preadipocytes with the various ginseng extracts as well as a specific inhibitor of TLR4 and measured Il-6 gene expression (a known downstream target of Regulation of inflammatory gene expression by AQ ginseng extract sub-fractions. The AQ ginseng extract was further fractionated into polysaccharide and ginsenoside extracts. Graphs depict the differential effects of 50 mg ml À 1 polysaccharide and ginsenoside extracts on the expression of Il-6 (a), Ccl5 (b) and Tnfa (c) in differentiated preadipocytes. Fold changes are relative to the control (that is, cells incubated solely with serum-free maintenance media). Values were obtained from four independent biological replicates. *Po0.05. TLR4 signaling) (Figure 4 ). When differentiated preadipocytes were treated with a TLR4-specific activator (EK-LPS) and the TLR4 inhibitor, Il-6 expression was reduced by B58% (Po0.05). Differentiated preadipocytes treated with the 50 mg ml À 1 AQ extract and TLR4 inhibitor resulted in a 30% inhibition in Il-6 expression (P ¼ 0.06). Further fractionating the AQ extract into polysaccharides and ginsenosides revealed that only the polysaccharide fraction signaled via TLR4. Differentiated preadipocytes treated with 50 mg ml À 1 polysaccharides and TLR4 inhibitor reduced Il-6 expression by 43% (Po0.05), whereas no change in Il-6 expression was observed in cells treated with ginsenosides and the TLR4 inhibitor.
Ginseng extracts and adipocytokine secretion To confirm changes observed at the mRNA level, protein levels of IL-6, CCL5 and TNFa were measured in differentiated preadipocyte media following treatment with 50 mg ml À 1 of the various ginseng extracts. IL-6 secretion was significantly increased (Po0.002) in differentiated preadipocytes treated with the AQ extract, the polysaccharide extract and the ginsenoside extract (Figure 5a ). IL-6 secretion appeared to be slightly decreased in cells treated with the EtOH extract (P ¼ 0.02). CCL5 secretion was upregulated in differentiated preadipocytes treated with the AQ and polysaccharide extracts, but no change in CCL5 secretion was detected in cells treated with the EtOH or ginsenoside extracts (Figure 5b ). Significant changes in TNFa secretion could not be detected with any of the ginseng extracts because of low detection levels of this adipocytokine (data not shown).
DISCUSSION
The present study provides evidence demonstrating that different extracts of NA ginseng have distinct effects on differentiated preadipocyte signaling pathways. Microarray analysis revealed that the AQ extract had strong inflammomodulatory characteristics in differentiated preadipocytes, whereas the EtOH extract had little to no impact on gene expression. Neither extract appeared to affect preadipocyte differentiation. Fractionation of the AQ extract into polysaccharide and ginsenoside extracts provided insight into the bioactive molecules that regulate differentiated preadipocyte signaling pathways. We demonstrate here that NA ginseng polysaccharides appear to influence inflammatory pathways, as confirmed at both the mRNA and secreted protein levels. Moreover, using a specific TLR4 inhibitor led to a significant suppression of the polysaccharide-stimulated effects on differentiated preadipocyte inflammatory markers. Taken together, our results suggest that the polysaccharide component of AQ ginseng extract appears to convey a strong capacity to regulate inflammomodulatory pathways in differentiated preadipocytes.
The biological pathways affected by AQ extracts of NA ginseng were identified using global gene expression data coupled with functional pathway analyses, and include ribosome biogenesis, regulation of phosphorylation and several inflammatory pathways, such as cytokine/chemokine receptor binding and activity, and TLR signaling ( See Figures 1 and 2; Supplementary Table 1 ). This is particularly intriguing considering that inflammation is increasingly recognized as a hallmark of many metabolic conditions, including obesity. 12 Recently, substantial interest has focused on the modulation of key inflammatory receptors, such as TLR4, which are expressed in a variety of cells including adipocytes.
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TLR4 has been implicated in the pathophysiology of obesity because of the documented increase in inflammatory cytokines, such as IL-6, TNFa and members of the CCL family, observed following its activation. 18 Although very few studies have investigated ginseng as a potential activator of TLR4 signaling, recent research involving Asian ginseng supports our findings that Figure 4 . Ginseng extracts signal via the TLR4 pathway. Data represent Il-6 mRNA expression when 0.5 mg ml À 1 TLR4 inhibitor was added to differentiated preadipocytes treated with EK-LPS and ginseng extracts. Percent expression is relative to the untreated cells (i.e., differentiated preadipocytes treated with serum-free maintenance media). ( À ) indicates treatment without TLR4 inhibitor, ( þ ) indicates treatment with TLR4 inhibitor. Values were obtained from two independent biological replicates. Figure 5 . Secretion of inflammatory proteins in culture media of treated differentiated preadipocytes. Graphs depict the differential effects of ginseng extracts on the secretion of IL-6 (a) and CCL5 (b) in differentiated preadipocytes. Fold changes are relative to the control (that is, cells incubated solely with serum-free maintenance media). Values were obtained from four independent biological replicates. *Po0.05. a significant proportion of the inflammomodulatory activity of ginseng occurs via the TLR4 pathway. 2 Pannacci et al. 2 studied the effects of 4-weeks of oral consumption of ginseng in mice at various levels of exercise-induced immune suppression. Ginseng treatment increased the secretion of TNFa and IL1b in peritoneal macrophages, which was mirrored by changes in TLR4 expression. Although Pannacci et al. 2 did not allude to the bioactive component of ginseng responsible for TLR4 activation, the authors of a separate study suggested that plant polysaccharides signal through an evolutionarily conserved pathway that is present in different cells and tissues throughout the organism. 5 Here, the authors demonstrated that polysaccharides, including those from NA ginseng, interact with TLR4 receptors on macrophage to induce activation and translocation of NFkB to the nucleus where it regulates the expression of hundreds of genes. 5 Our data suggest that ginseng signals through an analogous pathway in differentiated preadipocytes.
When in the presence of a specific TLR4 inhibitor, the stimulatory effects of the AQ and polysaccharide extracts on Il-6 expression decreased by 30% and 43%, respectively. Moreover, the increased suppression by the polysaccharide fraction was significantly greater than that of the AQ extract. Interestingly, the lack of results with ginsenosides suggests that while these bioactive molecules have recognized functions in other tissues, it appears that polysaccharides are the primary bioactive constituent of NA ginseng in differentiated preadipocytes. Notably, the incomplete inhibition of Il-6 expression with TLR4 inhibition also highlights the complexity of crude plant extracts on cellular signaling pathways. Our results suggest that NA ginseng functions not through a single pathway, but conversely possesses the ability to signal through multiple pathways. It appears likely that this breadth of activation confers the use of ginseng as a whole body wellness tonic, potentially having distinct functions in different tissues.
In addition to our TLR4 inhibitor data, previous compositional analysis of the AQ and EtOH ginseng extracts lends further support regarding the bioactive role of polysaccharides in differentiated preadipocytes. 3 Azike et al. 3 determined the ginsenoside and polysaccharide composition of our AQ and EtOH ginseng extracts. The AQ extract was found to have a dry weight composition of B14% ginsenosides and 10% polysaccharides, while the EtOH fraction was found to contain B28% ginsenosides and negligible amounts of polysaccharides. This compositional analysis reinforces that the inflammomodulatory effects of NA ginseng on differentiated preadipocytes are not dependent on ginsenosides, but rather polysaccharides. This finding is particularly noteworthy given that ginsenosides have been the primary focus of research to date regarding ginseng. In this respect, we believe that subsequent studies emphasizing the polysaccharide fractions will generate new potential for this herb as a NHP.
As previously stated, our data suggest that AQ ginseng activation of TLR4 increases expression of proinflammatory cytokines such as Il-6 and Tnfa. These cytokines subsequently stimulate the production of chemokines involved in monocyte adhesion and transmigration. 19 Chemokines, such as CCL2, CCL5 and the C-X-C motif family, are involved in cell-to-cell signaling through specific cell surface G-protein-coupled receptors. These G-protein-coupled receptors trigger a number of cellular processes, including exocytosis, proliferation, differentiation and apoptosis. 19 As shown in Supplementary Table 1A, the AQ ginseng extract activated the G-protein-coupled receptor-binding pathway. This signifies that not only are chemokines being upregulated by the AQ ginseng extract, but that it may also be stimulating macrophage recruitment and locomotory behavior. For monocyte migration to occur integrins must be activated to provide docking sites at the blood-epithelial cell barrier. 19, 20 Interestingly, the AQ ginseng extract downregulated two integrins: integrin alpha 8 and integrin, beta-like 1. This would suggest that polysaccharides in ginseng may trigger an inflammatory response in differentiated preadipocytes, but simultaneously prevent macrophage adhesion; however, this can only be elucidated by using a co-culture experimental system. The regulation of adipocyte integrins may offer a partial explanation for the previously reported whole-body anti-inflammatory effects in mice and humans treated with various ginsenosides. 20, 21 More importantly, it suggests further research is needed to determine if ginseng is stimulating a local inflammatory event in adipocytes or, alternatively, whether adipocytes are contributing to an overall systemic response.
In an effort to further investigate the pathways activated by NA ginseng and validate the significance of our mRNA data, we studied the secretion of IL-6, CCL5 and TNFa proteins. In concordance with gene expression data, the AQ and polysaccharide extracts both significantly increased the secretion of IL-6 and CCL5 ( Figure 5) ; however, although mRNA expression was greater in the AQ extract the magnitude of protein secretion was greater with the polysaccharide extract. While such discrepancies between mRNA and protein have been previously reported, it is important to recognize that transcript stability, translation, post-translational modifications and secretion pathways could all contribute to protein abundance. 22 Consequently, IL-6 protein secretion differed from mRNA levels and was significantly increased with the AQ extract, as well as polysaccharide and ginsenoside extracts. The significance of TNFa gene expression was also lost in protein secretion as it was barely detectable in culture media. Our data suggest that NA ginseng does have an impact on the differentiated preadipocyte secretome; however, additional studies are required to elucidate the mechanisms regulating protein synthesis.
Although the current study has highlighted the pathways triggered by NA ginseng in differentiated preadipocytes and demonstrated extract-specific bioactivity, certain limitations must be acknowledged. First, the use of isolated cells in culture is an important first step to unravel the pathways activated by ginseng, but this experimental approach prevents our ability to comment on the role of ginseng in adipose tissue. Indeed, considerable crosstalk between the various cell types within adipose tissue is known to occur, which means that the activation of inflammatory pathways in adipocytes may not reflect the inflammatory status of the tissue as a whole. An important next step in elucidating the role of NA ginseng in adipose tissue will benefit from using adipose tissue explants and adipocyte-macrophage co-culture systems. Second, the nature of our extracts means that we do not know whether it is a single ginseng polysaccharide or all ginseng polysaccharides that are responsible for the regulation of differentiated preadipocyte gene expression and inflammatory protein secretion. Although we appreciate that the isolation of a single bioactive molecule may be of relevance to some researchers, we were particularly interested in studying crude extracts in order to account for possible interactions between ginseng molecules. These crude extracts will be more readily positioned as a NHP in comparison with an isolated molecule.
In conclusion, we have shown that various NA ginseng extracts demonstrate specific bioactivities, where the AQ extract, and in particular the polysaccharide extract, triggers an inflammomodulatory response in differentiated preadipocytes. We demonstrated that Il-6, Ccl5, Nfkb and Tnfa were upregulated at the mRNA level via the TLR4-signaling pathway. Furthermore, we show that these effects are also reflected at the protein level through the increased secretion of IL-6 and CCL5. This work provides evidence of the distinct bioactivities of different ginseng extracts on differentiated preadipocyte signaling pathways, and importantly highlights the inflammomodulatory role of ginseng polysaccharides on differentiated preadipocytes. The study of these ginseng extracts in adipocytes requires further work, but these results suggest that this avenue of research is relevant and will generate important knowledge to better understand ginseng bioactivity.
